VenGrowth Asset Management Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 109

  • Portfolio
  • 1

  • Exits
  • 65


VenGrowth Asset Management General Information


VenGrowth Asset Management was a private equity and venture capital firm based in Toronto, Canada. The firm backed technology and life sciences companies, as well as more traditional manufacturing and service businesses. On September 6, 2011 Covington Capital acquired the firm's funds including New Generation Biotech (Equity) Fund, The VenGrowth Investment Fund, The VenGrowth II Investment Fund, The VenGrowth III Investment Fund, The VenGrowth Traditional Industries Fund and The VenGrowth Advanced Life Sciences Fund.

Contact Information

Year Founded
Investor Status
Primary Investor Type
Venture Capital
Other Investor Types
Asset Manager
Primary Office
  • 105 Adelaide Street West
  • Suite 100
  • Toronto, Ontario M5H 1P9
  • Canada

VenGrowth Asset Management Investments (109)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Trillium Therapeutics (acquired 2013) 12-May-2011 Later Stage VC 000 Biotechnology Generating Revenue 000 000000è00 00.0
Interface Biologics 10-Jan-2011 00000 00000 000 Drug Delivery Generating Revenue 0000000 000000 00.0
BTI Systems 10-Nov-2010 00000 00000 0000 Media and Information Services (B2B) Generating Revenue
VirtaMove 07-Sep-2010 0000000000 Business/Productivity Software Generating Revenue 00000 000000000
FUJIFILM VisualSonics 12-Nov-2009 00000 00000 0000 Diagnostic Equipment Generating Revenue
Roll-Tite 16-Apr-2009 0000000000 Machinery (B2B) Generating Revenue
Interface Biologics 11-Dec-2008 00000 00000 00.000 Drug Delivery Generating Revenue 0000000 000000 00.0
Great Lakes Food 01-Dec-2008 00000 00000 000 Food Products Generating Revenue 0000 00000
BTI Systems 06-Nov-2008 Later Stage VC 0000 Media and Information Services (B2B) Generating Revenue
Party Packagers 30-Oct-2008 PE Growth/Expansion 00.00 Specialty Retail Profitable 0000 00000
You’re viewing 10 of 109 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VenGrowth Asset Management Exits (65)

Company Name Exit Date Exit Type Exit Size
Interface Biologics 01-Jul-2021 Secondary Transaction - Private
Axela 01-Nov-2017 000000000000000000 00.000
Comtrad Strategic Sourcing 20-Oct-2017 0000000000
Dye & Durham eCore 31-Mar-2017 000000000000000000
BTI Systems 01-Apr-2016 000000000000000000 000.00
Nakina 31-Mar-2016 000000000000000000
Paintearth Energy Services 01-Nov-2015 000 00 00000000
Trillium Therapeutics (acquired 2013) 09-Apr-2013 000000000000000000 00.000
Cytochroma (Drug Discovery) 04-Mar-2013 Merger/Acquisition 00000
Azelon Pharmaceuticals 01-Jan-2013 Bankruptcy: Liquidation
You’re viewing 10 of 65 exits. Get the full list »

VenGrowth Asset Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial